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Executive summary  
Antibiotic use (ABU) is often described as a key driver of antibiotic resistance (ABR) (Adeyi et 
al. 2017). A particular concern is the continued increasing usage in the livestock sector (Van 
Boeckel et al. 2014), especially in low and middle income country (LMIC) settings (Klein et al. 
2018). However, currently we lack reliable data on the volume, mode and reasons for 
antibiotic use. Improving the surveillance and understanding of antibiotic use is a key 
objective in the OIE’s strategy on AMR (OIE 2016), the FAO’s action plan (Food and Agiculture 
Organisation of the United Nations 2016), and in the WHO’s Global Action Plan (WHO 2015). 
In line with the CGIAR AMR strategy (Wieland et al, 2018) the Improving Human Health 
programme supported a workshop to bring together researchers with experience of 
collecting ABU data at a granular level.  
Workshop participants included representatives from ILRI, LSHTM, FAO, SLU, the Vietnam 
Academy of Social Science, and the Universities of Liverpool and Makerere. Experiences were 
presented from researchers working in Cambodia, Ethiopia, Malawi, Tanzania, Thailand, 
Uganda, and Vietnam.  
Experience of tools used to measure ABU highlighted similar strengths and weaknesses to 
that of a previous review (Queenan et al. 2017b). Being site and sector specific, the tools 
presented were able to gather rich qualitative information, which is recognised as being 
pivotal in understanding the context of ABU and the complexity of the drivers surrounding 
usage. However, while some of the tools were able to generate proportional quantitative data 
on ABU, none were able to generate any level of meaningful and reliable volumetric data, an 
aspect which is desired by many stakeholders for ABU surveillance systems.  If such systems 
are to contain elements of volumetric data, then the challenge to find effective methods to 
collect this information need to be overcome.  
While the harmonisation of tools used to collect ABU data across human and animal use was 
viewed as desirable in working towards a One Health approach to the issue, it was recognised 
that this goal presents key challenges. The simplification that would need to take place to 
allow a tool to be used in multiple settings without taking too much time of interviewees 
would limit its ability to collect finely granular local level data. It was also recognised that an 
advantage of having multiple tools at this point in time was that these provide a multifaceted 
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approach to data collection to find the best solutions, and a single tool could miss crucial 
aspects of information vital to our understanding of ABU. An alternative to a completely 
harmonised tool could be to have one with a core structure which sets out a range of data 
collection objectives, with additional parts which, using defined methodologies, could be 
adapted to particular local settings, with the vision to move towards a harmonised tool in the 
future. 
Workshop participants emphasised that to interpret data collected through an ABU 
surveillance system, the complex systems surrounding ABU and the drivers which influence 
them must be understood and all actors in the system engaged with. Frameworks should be 
set out to allow critical appraisal of the usefulness of collected data to ensure that effective 
intervention strategies are applicable at the local level and allow recognition of what data is 
not being captured.  
The shared experiences of the researchers who attended this meeting demonstrated that 
several ABU data tools exist which are able to capture granular level information. Further 
work is needed to establish whether the tools presented are sufficient to evaluate ABU in a 
surveillance scenario which is useful for policy planning within a ‘One Health’ context.   
Following on from the workshop, recommendations for further work include; 1) comparison 
of the existing data collection tools from the livestock and human sectors, 2) ascertaining 
whether generation of specific volumetric data is necessary for ABU surveillance, 3) 
establishing which aspects of data collection could be harmonised across sectors, and 4) 
understanding what resources would be needed to upscale site-specific research into a 
surveillance programme.  
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Introduction  
Antibiotic use (ABU) is often described as a key driver of antibiotic resistance (ABR) (Adeyi et 
al. 2017). Use of antibiotics in animals is understood to be increasing (Van Boeckel et al. 2014), 
and this has been the focus of concern internationally (World Health Organisation 2015; OIE 
2016). A particular concern has been placed on increasing usage in low and middle income 
country (LMIC) settings (Klein et al. 2018) but at the same time we lack reliable data on the 
volume, mode and reasons for use. Improving the surveillance of antibiotic use and 
understanding of antibiotic use is a key objective in the FAO action plan (Food and Agiculture 
Organisation of the United Nations 2016) as well as in the WHO’s (2015) Global Action Plan. 
This is both important to provide more accurate data on levels of use but also data that can 
be analysed in conjunction with ABR data to understand the linkages between ABU and ABR. 
However, as yet there are no agreed protocols for the collection and comparison of AMU data 
in animal and human populations. 
 
Existing ABU analyses rely on partial data for example ‘consumption’ data provided by the 
IMS Health database (e.g. Collignon et al. 2018) or estimates of consumption data from 
member countries provided to OIE or WHO. Such data however are not sufficiently finely 
grained to guide interpretation or intervention at the national or sub-national level (Queenan 
et al. 2017b). A review of methods and metrics for measuring antimicrobial use demonstrated 
that there are multiple approaches, and no standardised tool (ibid). In November 2017, a 
group of 38 researchers, health practitioners and policy professionals were brought together 
in London for a roundtable to discuss how best antibiotic use can be measured at a granular 
level (Queenan et al. 2017a). This is a major challenge across different settings given the 
variety of antibiotics in use, the variety of sources and supply chains for antibiotics, the large 
size of informal markets and the difficulty of knowing what is prescribed and what is finally 
used by an individual, and for how long. Even more challenging is how we might meaningfully 
measure and compare antibiotic use across human and livestock sectors, which includes not 
only terrestrial farming but also aquaculture (fishery) use. The methodological issues raised 
included how to generate metrics for volumes that can be comparable with those generated 
for human health, and that can be captured reliably on the ground; around devising indicators 
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that can be meaningfully interpreted to assess unnecessary use; and around understanding 
the reasons for antibiotic use. 
 
Since the time of the LSHTM meeting in November 2017, various studies linked to the CGIAR 
Research Programme (CRP) Livestock and CRP Agriculture for Nutrition and Health (A4NH) as 
well as other research groups that are expanding their methodologies from the public health 
field have been collecting data on the use of antibiotics in animals. These studies use different 
approaches, and likely answer different questions within the area of antibiotic use. 
Responding to the need to share experiences from using different approaches and tools used 
by public health and veterinary sectors, a workshop was convened in Uganda in October 2018 
to see whether it may be possible to generate comparable data through unifying methods 
and metrics. This workshop brought together public health and veterinary researchers to 
discuss ongoing work and develop a common understanding on what resolution for 
measurements in the livestock sector is needed and feasible given variability in livestock 
production systems. 
 
The meeting objectives were: 
 
• To understand the range of questions that existing AMU data collection activities 
have been answering.  
• To share and compare experiences with different methodological approaches to 
studying AMU. 
• To consider whether a shared framework / tool or suite of tools may be usefully 
created that can generate comparable data across settings, and that may be 
comparable with data on human use. 
• Map complexities around measuring AMU 
 
The workshop was held over two days, the details of the agenda can be found in Appendix 2. 
Following a short introduction where participants had the chance to get to know each other 
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presentations were given by researches working in the field, who shared their experiences of 
using different tools to collect antibiotic usage data. Each researcher gave a short 
presentation describing their work reflecting on the points in the following table: 
Table 1. Points of discussion for ABU tools  
1. Brief overview of study objectives and tool used 
2. Key results/findings if available, focus on AMU indicator findings 
3. Did the study cover any One Health issues? If so which ones and how? 
4. Comment on strengths and weaknesses of the tool used  
5. Explain key challenges encountered overall 
6. Explain key challenges encountered to ‘quantify’ use/dosage & how they have dealt with it 
7. Any surprises in the field that the tool was not able to capture? 
8. Remaining gaps in the tools, suggestions on how to address these 
 
Researchers then took questions from the other delegates. At the end of the first day, key 
questions and themes arising from the presentations and discussions were noted and 
informed the topics for group discussion on day two. On day two, delegates were split into 
three groups and using a bus-stop approach each group discussed three themes: theme  1, 
led by Ulf Magnusson (SLU, Sweden) focused on the appropriate use of antibiotics; theme 2, 
led by Barbara Wieland, focused on the quantification of use and dosage; and theme 3, led 
by Laurie Denyer Willis, focused on the ‘One Health’ aspects, specifically the 
human/animal/environmental interfaces, and the role of gender on the impact on ABU.   All 
three groups were encouraged to consider the phrasing of question used with the tools, 
involvement of other value chain actors, and ways in which harmonisation of tools could be 
achieved. In the afternoon of day two a, groups mapped out the complexities around the 
drivers of ABU at the farm level and in the wider context, followed by plenary discussion. 
 
This report begins with an overview of the tools being used to measure ABU presented at 
the workshop and the experiences of the researchers using them. Thereafter the report will 
outline the main themes and key points which arose during the group discussions and finish 
with a discussion of the drivers of ABU.   
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Experiences of researchers using tools to collect ABU data  
On the first day of the meeting eight researchers presented work looking at ABU, the tools 
used to collect the data, and their experiences of using these tools in the field. All field work 
discussed occurred in either Africa (Ethiopia, Malawi, Tanzania, and Uganda [represented 
twice]) or South-East Asia (Cambodia, Thailand, and Vietnam). A summary of the key study 
characteristics can be found in Table 2.  
Table 2. Key study characteristics  
 
 
Seven of the studies discussed focused primarily on understanding and/or measuring 
antibiotic use, with the remaining study (in Malawi) focusing primarily on antibiotic 
resistance, with usage being investigated as a risk factor for the development of resistance. 
Research questions relating to ABU fell into four main categories; 1) identification of drivers 
for ABU, 2) understanding knowledge, attitudes, and practices around ABU and use other 
veterinary drugs, 3) understanding the nature of how antibiotics are being used, and 4) 
measuring the quantity of antibiotics being used. Four of the studies focusing on antibiotic 
usage also collected data on the prevalence of antibiotic resistance bacteria within the sample 
site. One study (in Vietnam) also collected data on antibiotic quality.   
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All of the studies were primarily focused on livestock production, three looking at just pigs, 
and the others a mixture of livestock. Three of the studies also collected data on ABU in 
people. Other ‘One Health’ aspects that were discussed included; 1) the use of human 
antibiotics for farm animals, 2) disposal of antibiotics into the environment, 3) consumption 
of antibiotics in foods of animal origin (eggs, meat, and milk), and 4) the role of zoonotic 
diseases in ABU.  
 
Only the research in Vietnam included a longitudinal approach within the study, with bins 
being provided to store medicines packages, which were collected by researchers after one 
month. The remaining studies collected data at one point in time, something which many of 
the researchers acknowledged as a weakness in their studies.  
 
All but one of the studies used questionnaires as a data collection method, with five sites 
using the Open Data Kit (ODK) equipment for data entry. While the ODK was felt to be an 
effective and efficient method of data capture, it was mentioned that in some settings it took 
time to train enumerators to use the kit, and there were limitations placed on the length of 
participant responses. In the three studies which used either the AMUSE or AMIS data 
collection tools it was necessary to complete scoping activities of local drug suppliers and 
stores in order to ascertain which antibiotics were present in this setting, the time taken to 
complete this task being dependant on the number of outlets in the research area. Other 
methods of data collection included; 1) focal group discussions, 2) participant observation, 
and 3) in-depth interviews.   
 
All of the studies produced qualitative and quantitative, descriptive data describing some of 
the ‘whys’, ‘hows’ and ‘whens’ of antibiotic usage. The ability to collect this finely granular 
data was seen as a strength of the tools used, and key in understanding the drivers for 
antibiotic usage. Five of the studies were able to generate proportional quantitative data 
(such as the percentage of farmers with access to veterinary care, frequency of drug use, or 
the percentage of animal feed that contains antibiotics). Proportional data of this kind, if 
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reliable and repeatable, has the potential to allow comparisons to be made between settings, 
measure trends over time, and before and after interventions. None of the studies discussed 
used tools that were able to successfully generate volumetric data (such as mg of antibiotic 
per population corrected unit or defined daily doses [DDD] per number of people at risk) on 
ABU, which was noted as a limitation by the majority of researchers. Lack of information 
about drug doses, and reliable data on duration and frequency of treatment, were cited as 
some of the reasons for being unable to generate volumetric data using these tools. 
Additionally, lack of data on the specific reasons for usage due to absence of diagnoses meant 
that very few of the studies were able to comment on the ‘rational’ or ‘appropriate’ use of 
antibiotics.  
 
The other limitations of the data collection tools which were discussed included; 1) doubtful 
accuracy of the information collected due to lack of written records and recall bias of 
participants, with some researchers suggesting that participants should not be asked to recall 
data longer than a period of two months, and 2) social desirability bias of the participants 
inhibiting truthful answering of questions, especially in settings which have started to 
legislate on antibiotic use (e.g. in Vietnam since the Ministry of Agriculture and Rural 
Development banned the introduction of some antibiotics into animal feed at the start of 
2018).  
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Discussion groups 
Appropriate usage of antibiotics  
It was recognised that in order for the use of antibiotics to be considered completely 
appropriate then diagnostics are needed to allow clinical diagnoses to be made. Diagnostics 
of this kind (lab analysis, post mortem) are costly and frequently unavailable in LMIC settings 
and are one of the key bottlenecks for proper animal health care at the moment.  In most 
instances, diagnoses are made based on presenting clinical signs, the reliability of which is 
dependent on an individual’s skill and past experiences. The groups discussed that it was 
often farmers making the diagnosis themselves, sometimes in discussions with peers and 
neighbours. Sometimes service providers, such as vets or community-based animal health 
workers (CAHW) would be consulted, which would usually result in costs to the farmer. The 
reliability of vets and CAHWs is dependent on their ability to make an accurate clinical 
diagnosis, something which can vary greatly, due to level of training and experience. Decision 
tree were mentioned as a method of improving the rationale behind ABU, aiding decisions of 
vets and farmers on a course of action and which antibiotics to prescribe/use.  An example in 
Uganda was mentioned where workers in intensified farms had known about the varying 
competencies of different service providers and would use this knowledge to interpret the 
advice they received. Animal drug sellers are also known to provide advice to customers, and 
it was discussed how it would be difficult to capture the advice and information given during 
these encounters.  
It was noted that care should be taken when considering how to interpret the 
‘appropriateness’ of ABU. Interventions which aimed to improve ‘appropriate’ use of ABU did 
so at the individual, patient level and often failed to consider a wider approach and the 
influence antibiotics have had on the development of systems. Antibiotics could be 
considered elements of architecture in allowing intensive agricultural systems to develop and 
broader approaches such as structural adjustment programmes may be needed to address 
the ‘appropriateness’ of ABU at a larger scale.  
 
14 
 
Quantification of use and dosage  
Discussions around quantification of ABU came up in all three groups and covered a range of 
concerns (Figure 1).  
Figure 1. Questions raised concerning the quantification of ABU 
 
 
 
 
 
 
 
From a research point of view of the delegates present, it was postulated that measuring the 
quantity of antibiotics used was less important than knowing the proportion of inappropriate 
use and understanding the driverss for usage and the knowledge, attitudes and practices that 
surround usage.   
The generation of consumption data (such as mg/PCU/year or vDDD) as detailed in the OIE 
standards were discussed by the delegates who deliberated on the value of such information 
given the questionable reliability of macro level data and assumptions needed to generate 
the values. It was also felt that this type of data gave no information on the reason of use 
(prophylaxis vs. treatment) or if group treatment or individual application occurs.  
As in the fieldwork tool discussions on the previous day, it was noted that cross-sectional 
studies for data collection were of a single time point with limiting factors; 1) data is not 
representative of whole year, 2) seasonality is missed, and 3) user recall for more than a 
month difficult. It was considered better for data to be collected using longitudinal 
approaches. Example were given such as in Ethiopia where village level enumerators have 
been trained to collect data and in Uganda where record keeping books have been distributed 
coupled with regular follow-up visits from the researchers. Several delegates talked about 
trash/rubbish bucket methods to collect medicine packages over a certain period of time, 
Why do we need to 
quantify? 
What is the data 
going to be used for? 
What metrics do 
we use? 
How can we collect 
accurate data? 
How meaningful 
can this data be? 
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though they acknowledged that the reliability of this data could be varied and difficult to 
establish.  
Social desirability bias was discussed again, noting that there could be a lack of willingness to 
report ABU in some settings. It was discussed how it is important to gain the trust of 
interviewee, place emphasis on diseases and how they address challenges in their farms,  
involve local community leaders and ensure feedback sessions are organised to maintain 
engagement.  
Triangulation of data collection, either by including other value chain actors, or by using 
different data collection methods on the same value chain, was discussed as a method of 
validating the accuracy of data collected. It was mentioned that a three-tiered approach to 
data collection has started in Vietnam, using questionnaires, record books, and package bins 
to acquire data on ABU.  
 
‘One Health’ aspects (Human/animal/environment interface) and the role of Gender 
Experiences were shared on how to address issues around ‘One Health’ (OH) of ABU and how 
this could be implemented on the ground. Some of the technical issues around implementing 
a OH approach were discussed, such as funding and power imbalances, recognising that there 
is normally a greater focus on human health than animal and environmental health. Some 
delegates noted that while there has been government calls for a OH AMR platform, this often 
only results in cross sectoral representation at meetings with little joint implementation 
occurring at the local level. Concerns around zoonotic diseases were acknowledged to have 
improved multisectoral work, but some felt there was still a culture of blaming farmers rather 
than sharing the responsibility.  
 
The role of environmental aspects were discussed and noted that they were often neglected, 
with a focus on livestock only. While animal and antibiotic waste management formed part 
of some of the tools used, the data collected was often overlooked, and it was noted that 
there is potential for this to from a part of background surveillance.    
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When considering the role of gender, it was acknowledged that attention must be paid to the 
local context. Even when major shifts do occur in women’s empowerment, gender dynamics 
in dealing with service providers, such as vets and CAHWs, can mean that men speak to men, 
despite women being responsible for some of the animal health management, especially 
caring for sick animals.  
 
Tool harmonisation and surveillance  
When considering whether a shared framework/tool or suit of tools could be created to 
generate comparable data across setting and sectors, all delegates agreed that this was a 
desirable goal, but several limitations and risks of this approach were highlighted. Ideally a 
harmonised tool would facilitate the development of national and international surveillance 
systems for ABU, allow metanalyses to be performed, and promote the collection of data in 
a ‘One Health’ approach. It was noted that it was important for such a tool to be able to 
measure spatial and temporal trends, including seasonality variations, thus requiring a 
longitudinal aspect to be considered.  
It was acknowledged that the main strength of having a site-specific tool was in its ability to 
generate detailed, rich, and granular level data to facilitate contextual understanding of ABU 
at that site. This data is necessary for rapid situational assessments and to allow targeted 
policy and interventions. Creating a single harmonised tool that could be used across a variety 
of settings would require a degree of simplification and thus reduce the ability of the tool to 
collect local data as the content validity for specific sites would be reduced. Several delegates 
suggested that a solution would be to standardise part of the tool, and to set out a 
standardised methodology for adapting the remainder of the tool to become site specific.  
 
It was mentioned that while the harmonisation should be an end goal, we may not be ready 
to start the process just yet. An advantage of having numerous tools at this stage of research 
is that they can be tested against each other, exposing weaknesses and strengths, and that 
one tool may capture an element of AMU which has not yet been considered, and could prove 
an important aspect of understanding the topic.  
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It was also noted that it was important for surveillance work on ABU to continue to link back 
to data on ABR prevalence. An ABU surveillance system may provide an opportunity to collect 
ABR samples/data and aid epidemiological studies needed to elucidate these issues at both a 
national/macro and local level.  
 
Understanding the drivers of ABU 
In the afternoon of day two, delegates discussed how the reasons, incentives, and rationales 
which lead to antibiotics being used are numerous, varied, and complex. These ‘drivers’ come 
in many forms, act at different levels within the supply chain, and influence actors in different 
ways. Drivers may be classed as, for example, social, economic, political, industrial, 
geographical, ethical, and microbiological in their nature. They may exert a direct effect on 
ABU or interact with other drivers within more complex relationships. Using a systems-based 
approach to the value chain which antibiotics exist within offers an opportunity to 
comprehensively elucidate all significant drivers acting in the chain and design appropriate 
intervention strategies.  
The importance of attempting to understand these drivers in order not to forget the reality 
facing those who use and depend on antibiotics in their daily lives was noted. Forgetting or 
ignoring the drivers of ABU could lead to naïve and unrealistic expectations of how to reduce 
ABU and mitigate the problem of ABR.  
The groups discussed the various drivers which they considered had an impact on ABU, a 
summary of which can be found in Table 3. Three main levels of actors were considered; 1) 
farmers (animal owners and/or herdsmen), 2) suppliers (Agrovet shops, pharmacies, drug 
stores, vets), and 3) actors from a wider context (importers, exporters, pharmaceutical 
companies and their sales organisations, and wider policy environment and other 
stakeholders). A summary of the drivers the groups discussed can be found in figures 2, 3, 
and 4.  
On a particular note, the regulation of vaccinations as a driver was discussed by the group. It 
was considered that while antibiotics are readily available vaccinations are not as they are 
often regulated by government institutions and require a cold chain.  Vaccinations normally 
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need to be done at herd level and therefore require financial and physical resources as well 
as planning, whereas treatment of sick animals with antibiotics is normally at the animal level 
and often occurs without planning.  
It was discussed that farmers are concerned about the health and welfare of their animals, 
and financial constraints, pressure to intensify farming with limited land, and shifts to exotic 
breeds with higher susceptibility for disease can make disease prevention difficult. 
Antibiotics, as well as allowing these intensive or bio-insecure systems to be productive, also 
help to protect capital investments.  
 
Figure 2. Drivers for antibiotic usage identified at the farm level  
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Figure 3. Drivers for antibiotic sales  
 
Figure 4. Drivers for suppliers of antibiotics in the wider context  
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Conclusion 
The shared experiences of the researchers who attended this meeting demonstrated that 
several ABU data tools exist which are able to capture granular level information. However, 
it must be established whether the tools presented are sufficient to evaluate ABU in a 
research or surveillance scenario.  Additionally, while the majority of the tools presented were 
able to provide detailed qualitative information about usage, few were able to provide 
reliable and meaningful volumetric data at the local user level.  
Once it has been established whether the existing ABU data collection tools are fit for purpose 
then it can be considered whether it is possible to construct a harmonised, or partially 
harmonised, tool which could be developed into a multi-sectoral surveillance system. For 
such a harmonised tool to exist, it must be determined what the tool should measure and if 
can be upscaled from site specific research into national and international surveillance. To 
ensure that such data are interpreted appropriately, the complex systems surrounding ABU 
and the drivers which influence them must also be understood and all actors in the system 
engaged with. Frameworks should be set out to allow critical appraisal of the usefulness of 
collected data to ensure that effective intervention strategies are applicable at the local level 
and allow recognition of what data is not being captured.  
 
Next steps 
Following on from the meeting, a consultant has been hired to continue evaluating the data 
collection tools with the following objectives: 
• A detailed comparison of the data collection tools (for both livestock and human 
sectors) in order to establish which approaches and questions are most useful in being 
able to capture the necessary data on ABU.  
• To ascertain whether volumetric data is a necessary requirement of a surveillance 
system of ABU at this time, and whether it is possible to collect this data in an 
economical manner in what are often resource limited settings.  
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• To establish which aspects of data collection could be harmonised across the human 
and livestock sectors in a way that provides information which is useful to public 
health policy decisions.   
• To understand what resources would be needed to upscale site-specific research into 
a surveillance programme and explore which possible barriers could obstruct this 
process.  
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Appendix 2: Meeting programme 
Workshop on collecting data on Antibiotic 
Use in Animals 
 
22-23rd October, Entebbe, Uganda 
Programme 
22nd October Activity Methods, presenter/chair 
Afternoon (13-
17.30) 
Overall introduction, setting the scene (30 min) Presentation – Barbara 
Wieland 
Break at 3pm Presentations on different tools and experiences 
from different countries 
- AMUSE Uganda (Amia Winfred) 
- AMIS Uganda (Miriam Kayendeke) 
- Malawi (Cat Wilson) 
- AMUSE Ethiopia (Biruk Alemu) 
- Vietnam: anthropological considerations 
(Dr Hang) 
- AMUSE in Thailand (Ulf Magnusson) 
- Cambodia AMU surveys (Gunilla Ström) 
- Tanzania (Mark Caudell)  
 
Laurie, Barbara and Nichola taking notes on key 
questions that were given to presenters (to 
inform planning of day 2): 
 
- Brief overview of study objectives and 
tool used 
- Key results/findings if available, focus on 
AMU indicator findings 
- Did the study cover any One Health 
issues? Which ones? How? 
- Comment on strengths and weaknesses 
of the tool they used  
- Explain key challenges encountered 
overall 
- Explain key challenges encountered to 
‘quantify’ use/dosage and how they 
have dealt with it 
- Any surprises in the field that the tool 
was not able to capture? 
- Remaining gaps in the tools, suggestions 
on how to address these 
 
10 min  presentation, 5 min 
questions (chair Ulf 
Magnusson) 
 
23rd October   
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Morning 
(08.30-12.30) 
Use of data on AM use? Presentation Nichola 
- One Health 
- Surveillance 
- Modelling and evaluation 
 
Group discussion to generate a framework of 
the different questions being asked, and to map 
on which tools are suitable to answer each sets 
of questions. 
 
Use discussion to define Bus-stop questions 
 
(Chair Laurie Denyer Willis) 
Break at 10am Group work on specific points emerging in the 
discussions in the morning 
Possible discussion points that somehow should 
be covered in the bus stops: 
- Volume: how to measure volume 
- Why and when they are used 
- Types of antibiotics and their 
appropriate use 
- Frequency (prevention vs. treatment) 
 
Measures? How count 
How to ask? 
Sampling? How many needed 
One Health 
 
What is missing in the tools we have? How could 
the missing issues be incorporated?  
- Challenges encountered during field 
work? 
- How to capture human antibiotic use for 
animals and vice versa and how can data 
collection on use be coordinated 
between humans and livestock use? 
Why needed? Do we have enough 
evidence for that? Should it be 
encouraged? How? 
- Can data collection tools be 
harmonised? 
Bus-stop approach on 4 
questions 
12.30 Lunch   
Afternoon 
(until about 
3.30pm) 
Plenary discussion 
Mapping of AM-use complexity, which questions 
on what issues?  
(Chair Barbara Wieland) 
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